The Vitamin C Conspiracy Articles proving Vitamin C cures infections
Introduction. Hippocrates referred to an intermittent fever that could very possibly have been undulant fever. If that is so, the disease we know today as brucellosis was already known as long ago as 400 B.C. It is certainly known to have existed along the shores of the Mediterranean for five or six hundred years. It was not until the 18th Century that the medical world made a special study of it. The name “Malta Fever” was applied to it about this time.
Murston was the first author to describe it accurately and differentiate it clinically and pathologically from typhus and typhoid This was in 1859. Wright and Douglas, in 1897, published the result of experiments proving that the disease could be diagnosed by the sero-agglutination method.
In 1904, the British Admiralty and War Office sent an investigating committee to Malta to study the disease. After three years, this body compiled an exhaustive report. Our present knowledge of undulant fever is based on that report.
The causative factor, according to Dr. Bruce, one of the commission, was the Micrococcus melitensis, in later years known as the brucellosis bacillus. It is found in the liver, kidneys, spleen, lymphatics and salivary glands, in the blood, bile, urine and milk.
It is very widely distributed throughout the entire world and is truly described, in contemporary literature, as a cosmopolitan disease. It has been erroneously diagnosed as rheumatic fever, typhoid, typhus, malaria or kala-azar. The diagnosis will be clarified by the result of agglutination tests and hemocultures.
The symptoms will be fairly well described in the case reports to follow. They vary from one case to another, but have a fairly typical general picture.
Case 1. Mrs. D., 35 years old, weight 130 pounds.
Symptoms:
Appendix, removed 1946; it was normal. X-rays of hips and other joints in 1946 were all negative. Definite diagnosis of undulant fever was made in 1946.
Brucellosis abortus vaccine was given bi-weekly with considerable alleviation of symptoms. The fever still returned at same intervals, with the same symptoms, somewhat diminished.
March 1953. Started taking 3000 mg. daily of ascorbic acid. Shortly afterwards the patient moved from this neighborhood.
June 1954. She wrote as follows:
November 3, 1954 she wrote again:
Case 2. Mr. 5., 52 years old, height 6 feet 2 inches, weight 129 pounds.
Symptoms (beginning July 1947):
Since 1947 he had spent nineteen months in a hospital and had been unable to work for three years.
September 1953. Started 3000 mg. daily ascorbic acid: no other treatment.
May 3, 1954.
Case 3. Mr. D. F., 28 years old, weight 140 pounds, height 5 feet 10 inches.
Symptoms (beginning about January 1951):
November 1953. Started on 3000 mg. ascorbic acid daily. No other treatment.
June 8, 1954. All pains gone. No fever for four months. Fatigue still present but diminishing.
November 3, 1954. Symptom-free. Working full time. New outlook on life.
February 21, 1955. No further symptoms.
Case 4. Mr. E. 5., 56 years old, weight 125 pounds.
Symptoms (diagnosed as undulant fever, September 1948):
September 16, 1954. Started to take 4000 mg. daily ascorbic acid.
October 14, 1954, one month later, there was definite improvement.
February 23, 1955.
Case 5. Miss H. D., 38 years of age, height 5 feet 6 inches, weight 130 pounds. History of undulant fever since childhood. Definite diagnosis of brucellosis was made on several occasions.
Symptoms:
This patient has been taking 3000-4000 mg. of ascorbic acid daily for the past six months. There has been no apparent result. She has refused intravenous injections of sodium ascorbate. It may be that she is not getting sufficient absorption of ascorbic acid to be of any therapeutic benefit on account of the intestinal disturbance. This is her worst symptom.
Case 6. Mrs. R. H., 42 years of age, weight 120 pounds. Undulant fever from childhood.
Symptoms:
Mrs. H. has been taking 4000 mg. ascorbic acid daily since October 29, 1954. She has not had any evident result, and has consented to take sodium ascorbate intravenously.
From my experience in this treatment, sodium ascorbate 1000 mg. in 2 cc. ampules should be given intravenously two or three times a week from the beginning in all cases.
Case 7. Mr. W. M., 38 years of age. He states that in all probability he has had undulant fever since early childhood.
Early symptoms:
Symptoms (November 11, 1954):
November 11, 1954. Started taking ascorbic acid 6000 mg. daily; later reduced to 4000 mg. daily.
February 23, 1955.
Case 8. Mr. P. B., high school teacher, age 56 years.
Symptoms (January 14, 1955):
January 14, 1955. Started taking 4000 mg. ascorbic acid daily. February 20, 1955. Reports that he is very definitely improved. Almost free from pain; fatigue disappearing; appetite improved.
February 26, 1955. Having attack of fever; feeling quite miserable. Will resort to the intravenous method after two months if improvement is not more marked.
Case 9. Mr. F. S., age 48 years, weight 148 pounds, height 5 feet 8 inches.
Symptoms (January 18, 1955):
January 18, 1955. Started to take 4000 mg. ascorbic acid daily.
February 28, 1955.
Case 10. Mrs. E. S., age 43 years, weight 120 pounds.
Symptoms (onset October 1950):
Present symptoms (January 18, 1955):
Present condition (February 28, 1955):
Case 11. Miss F. S., 19 years of age, weight 145 pounds. When seventeen years of age had an attack of undulant fever. Positive test for brucellosis in 1952.
Present symptoms (December 30, 1954):
Between ages of seventeen and nineteen, the patient was in fairly good health. With the exception of a considerable measure of physical inertia, there were no other symptoms relevant to undulant fever, In all probability she had undulant fever between the ages of 15 and 17 when she had the above symptoms, with one exception. When 15 to 17 years old, she ran a consistent fever of 99° F. No fever during present attack.
Present condition (February 28, 1955):
Case 12. Mr. B. S., 17 years old, weight 130 pounds, height 5 feet 9 inches, high school student.
Present symptoms (onset 1950):
January 18, 1955. Started to take 4000 mg. ascorbic acid daily.
February 28, 1955. Mother said he was definitely improved less fatigue; pains gone; symptom-free. It will require another month or two to make a proper appraisal.
The therapeutic use of ascorbic acid was suggested to the writer by reading reports, one by Dr. W J. McCormick,1 who reported spectacular results. He stated that “he has found ascorbic acid by mouth and sodium ascorbate intravenously better than any or all of the antibiotics for infectious diseases, bacterial or viral.”
Patients suffering from brucellosis have remissions during which time they are almost free from symptoms. This is especially true of the less severe cases. In considering new cases, this must be taken into consideration. Accurate appraisal can be made only after close observations carried out over a year or longer.
If this treatment proves to be effective for undulant fever, its possibilities are great. In New Jersey alone, some authorities say that there are probably 30,000 new cases yearly. Some authorities believe that as much as 10 per cent of the entire rural population of the United States is infected. Statements similar to the above will be found in a booklet by Dr. Alice C. Evans,2 entitled “Crippler in Disguise,” the story of undulant fever in America, published by the National Society for Crippled Children and Adults. This would make the number of cases of undulant fever in the entire United States around 8,000,000. The United States probably pasteurizes as high a percentage of its milk as any country in the world. Therefore, the number of cases throughout the world, where the raw milk of cows and goats is used, must be staggering.
The author believes that this preliminary study justifies the interest of those who have better opportunities to study this Problem on a suitable scale.
1. McCormick, W. J.: Ascorbic Acid as a Chemotherapeutic Agent. ARCH. PEDIAT., 69: 151-155, April 1952.
2. Evans, Alice C.: Crippler in Disguise. Pub. by National Society for Crippled Children and Adults.
From Archives of Pediatratics, Volume 72, Number 4, April, 1955, pp. 119-125.
[Note: The original article was densely formatted with many contiguous sentence fragments in paragraph format. In the interest of clarity, numbered and bulleted lists have been used instead, with rules added between patient records. Content and enumeration (where employed) are unchanged . -AscorbateWeb ed.]
HTML Revised 15 March, 2003.
Corrections and formatting © 2003 AscorbateWeb